{"nct_id":"NCT01627327","title":"Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease","status":"COMPLETED","status_verified_date":"2017-10","start_date":"2012-04-01","start_date_type":null,"primary_completion_date":"2012-12-01","primary_completion_date_type":"ACTUAL","completion_date":"2012-12-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}